Shopping Cart
- Remove All
- Your shopping cart is currently empty
Lerdelimumab (CAT-152) is a recombinant human monoclonal antibody of the IgG4 subclass targeting TGF-β2. It holds potential as an anti-scarring agent in glaucoma research [1] [2].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | Inquiry | Backorder |
Description | Lerdelimumab (CAT-152) is a recombinant human monoclonal antibody of the IgG4 subclass targeting TGF-β2. It holds potential as an anti-scarring agent in glaucoma research [1] [2]. |
Cas No. | 285985-06-0 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.